參考文獻 |
1. 蔡文正, 龔佩珍, 張永賢, 童承福. 民眾對中醫藥的認知度, 信賴度, 使用度及其相關因素之探討. 中醫藥年報. 2007.
2. Han Y, Xu J, Zhu Q, Yang L, Wang Y, Luo H, Zhang T. Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection. Chin Med. 2023;18(1):45.
3. Yan S, Jiang Y, Yu T, Hou C, Xiao W, Xu J, et al. Shengjiang San alleviated sepsis-induced lung injury through its bidirectional regulatory effect. Chin Med. 2023;18(1):39.
4. Jiang RY, Fang ZR, Zhang HP, Xu JY, Zhu JY, Chen KY, et al. Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer. Chin Med. 2023;18(1):125.
5. Lyu M, Fan G, Xiao G, Wang T, Xu D, Gao J, et al. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B. 2021;11(11):3337-63.
6. Lu W, Wenfeng Z. Zhang Xichun’s academic thought of treating consumptive thirst. Journal of Changchun University of Chinese Medicine. 2020.
7. Meng X, Liu X, Tan J, Sheng Q, Zhang D, Li B, et al. From Xiaoke to diabetes mellitus: a review of the research progress in traditional Chinese medicine for diabetes mellitus treatment. Chin Med. 2023;18(1):75.
8. 朱橚. 普濟方 (四庫全書本)1406.
9. Chung MC, Su LJ, Chen CL, Wu LC. AI-assisted literature exploration of innovative Chinese medicine formulas. Front Pharmacol. 2024;15:1347882.
10. 衛生福利部. 臺灣中藥典第四版2021.
11. 陳佳玲. 禁用中藥材一覽表. 藥師周刊電子報. 2020(2179).
12. Agrawal R, Srikant R, editors. Fast algorithms for mining association rules. Proc 20th int conf very large data bases, VLDB; 1994: Santiago.
13. F.R.S. KP. X. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philosophical Magazine Series 1. 2009;50:157-75.
14. Ji T. Clinical observation on treating diabetic peripheral neuropathy with Buyang Huanwu decoction. Clinical Journal of Chinese Medicine. 2014;6:74-5.
15. Meizhen Z, Xiaohui H, Yiting T, Yupeng C, Puyu HE, Liming Z, et al. Efficacy and safety of Buyang Huanwu decoction for diabetic peripheral neuropathy: a systematic review and Metaanalysis. J Tradit Chin Med. 2023;43(5):841-50.
16. Bao XY, Deng LH, Huang ZJ, Daror AS, Wang ZH, Jin WJ, et al. Buyang Huanwu Decoction Enhances Revascularization via Akt/GSK3β/NRF2 Pathway in Diabetic Hindlimb Ischemia. Oxid Med Cell Longev. 2021;2021:1470829.
17. Liu M, Pan Q, Chen Y, Yang X, Zhao B, Jia L, et al. NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice. Evid Based Complement Alternat Med. 2015;2015:242517.
18. Yang S, Liu M, Chen Y, Ma C, Liu L, Zhao B, et al. NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice. Scientific Reports. 2018;8(1):9158.
19. Zhang Y, Zhang Y, Yang C, Duan Y, Jiang L, Jin D, et al. Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study. Front Endocrinol (Lausanne). 2022;13:1037564.
20. Fu Y, Yuan J, Sang F, Shao M, Yan S, Li L, et al. Biejiajian Pill Ameliorates Diabetes-Associated Atherosclerosis through Inhibition of the NLRP3 Inflammasome. Evid Based Complement Alternat Med. 2022;2022:9131178.
21. Fan Y. Clinical Study of Biejiajian Pill in the Treatment of Diabetes Mellitus Complicated with Arteriosclerosis Obliterans of Lower Extremities. Zhengzhou, China: Henan University of Traditional Chinese Medicine. 2012.
22. Ma LL, Yuan YY, Zhao M, Zhou XR, Jehangir T, Wang FY, et al. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats. Chin J Nat Med. 2018;16(6):411-7.
23. Chen X, Bai X, Liu Y, Tian L, Zhou J, Zhou Q, et al. Anti-diabetic effects of water extract and crude polysaccharides from tuberous root of Liriope spicata var. prolifera in mice. J Ethnopharmacol. 2009;122(2):205-9.
24. 赖俊生 卢, 卢洁光, 卢品香. 麦冬汤合牛膝饮加味治疗2型糖尿病合并高血压的临床效果及安全性分析. 心血管病防治知识. 2021;11(3):6-8.
25. 赵维纳, 李思瓯, 曲世巍, 华文芳. 中西医结合治疗糖尿病周围神经病变 91 例. 中医研究. 2013;26(3):32-4.
26. Peng S, Xie Z, Zhang X, Xie C, Kang J, Yuan H, et al. Efficacy and Safety of the Chinese Patent Medicine Yuquan Pill on Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2021;2021:2562590.
27. GAO Z. Effect of Yuquan Pill on blood glucose fluctuation of diabetes mellitus patients receiving insulin therapy with deficiency type of qi and yin. Chinese Traditional and Herbal Drugs. 2015:2275-8.
28. Deng YQ, Fan XF, Wu GL. [Effect of yuquan pill on proinflammatory cytokines in patients with type 2 diabetes mellitus]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006;26(8):706-9.
29. Fei QZ, Ying W. Effect of Dioscorea opposita Thunb. Polysaccharide on glycolipid metabolism and oxidative stress in type 2 diabetic rats. Food Sci. 2017;38(05):262-6.
30. Lv J, Wei P, Bai F. Effects of Dioscoreae Rhizoma polysaccharide on platelet and enzyme activities in type 2 diabetic rats. Chin J Gerontol. 2017;37(13):3186-7.
31. Hu G, Yang B, Zhang Z. Effect of polysaccharides of rhizoma on blood glucose and insular function in diabetic rats. Shandong J Tradit Chin Med. 2004;4:230-1.
32. Li XiaoBing LX, Pei LanYing PL, Chen YuLong CY. The influence of Dioscorea Batatas polysaccharide on the glycolipid metabolism and oxidative stress of diabetic rats induced by STZ. 2014.
33. Zou G, Zhong W, Xu R, Shi C, Zhao S, Han Y, Liu L. The protective effects of catalpol on the islet cells in rats with type 2 diabetes mellitus. Chin J Integr Med Cardio-Cerebrovasc Dis. 2016;14(15):1727-9.
34. Wan G, Jiang R, Zhu H. Progress in studies of catalpol prevention of inflamation diseases. J Mod Med Health. 2019;35(23):3575-7.
35. Wang Y, Dai Z, Wang Q, He Y, Peng Y, Wu M, et al. Clinical Application of Traditional Chinese Medicine Therapy for Type 2 Diabetes Mellitus: An Evidence Map. Evid Based Complement Alternat Med. 2022;2022:2755332.
36. Hu Z, Liu X, Yang M. Evidence and Potential Mechanisms of Jin-Gui Shen-Qi Wan as a Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Front Pharmacol. 2021;12:699932.
37. Liang D, Qi Y, Liu L, Chen Z, Tang S, Tang J, Chen N. Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt/HIF-1α pathway. Chin Med. 2023;18(1):130.
38. Liang D, Liu L, Qi Y, Nan F, Huang J, Tang S, et al. Jin-Gui-Shen-Qi Wan alleviates fibrosis in mouse diabetic nephropathy via MHC class II. J Ethnopharmacol. 2024;324:117745. |